TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 213 filers reported holding TURNING POINT THERAPEUTICS I in Q2 2022. The put-call ratio across all filers is 3.08 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $9,284,000 | -48.1% | 345,791 | -7.8% | 0.03% | -46.7% |
| Q4 2021 | $17,883,000 | -26.7% | 374,910 | +2.1% | 0.06% | -34.1% |
| Q3 2021 | $24,385,000 | +3.3% | 367,081 | +21.3% | 0.09% | +8.3% |
| Q2 2021 | $23,607,000 | +12.0% | 302,578 | +35.7% | 0.08% | -3.4% |
| Q1 2021 | $21,087,000 | -35.4% | 222,931 | -16.8% | 0.09% | -42.4% |
| Q4 2020 | $32,667,000 | +36.7% | 268,091 | -2.0% | 0.15% | +11.0% |
| Q3 2020 | $23,899,000 | +68.5% | 273,571 | +24.6% | 0.14% | +41.7% |
| Q2 2020 | $14,183,000 | – | 219,584 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,737,297 | $176,802,000 | 6.75% |
| MPM BioImpact LLC | 308,686 | $19,938,000 | 5.30% |
| Burrage Capital Management LLC | 77,172 | $4,985,000 | 3.49% |
| Orbimed Advisors | 2,745,327 | $177,321,000 | 2.50% |
| Parkman Healthcare Partners LLC | 110,318 | $7,125,000 | 2.01% |
| SECTORAL ASSET MANAGEMENT INC | 284,486 | $18,375,000 | 1.69% |
| First Light Asset Management, LLC | 192,829 | $12,455,000 | 1.45% |
| Asymmetry Capital Management, L.P. | 22,608 | $1,460,000 | 1.12% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 35,000 | $2,236,000 | 0.74% |
| Prosight Management, LP | 25,602 | $1,654,000 | 0.71% |